Paul Delree
Gosselies, WAL, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Evaluation of short-course durvalumab combined with dose-dense EC in the neoadjuvant setting for locally advanced luminal B/HER2(-) or triple-negative breast cancer.
Journal: Breast cancer research : BCR
Published: March 17, 2025
Role of Myeloperoxidase in ROS Generation and Inflammation Response on Prostate Epithelial Cells.
Journal: Inflammation
Published: August 04, 2022
Antenatal Membranous Nephropathy and Type 2 (Axonal) Charcot-Marie-Tooth With Mutations in the Metallo-Membrane Endopeptidase Gene: A Call for Family Screening and Pharmacovigilance.
Journal: Kidney international reports
Published: April 12, 2021
2021 update of the GEFPICS' recommendations for HER2 status assessment in invasive breast cancer in France
Journal: Annales de pathologie
Published: March 24, 2021
MiR-210 Is Overexpressed in Tumor-infiltrating Plasma Cells in Triple-negative Breast Cancer.
Journal: The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society
Published: December 03, 2019
Glioblastoma in a fingolimod-treated multiple sclerosis patient: Causal or coincidental association?
Glioblastoma in a fingolimod-treated multiple sclerosis patient: Causal or coincidental association?
Journal: Multiple sclerosis and related disorders
Published: September 17, 2019
Tumor sequencing is useful to refine the analysis of germline variants in unexplained high-risk breast cancer families.
Journal: Breast cancer research : BCR
Published: May 06, 2019
Chromothripsis in an Early Recurrent Chordoid Meningioma.
Journal: World neurosurgery
Published: April 10, 2019
GEFPICS' guidelines for management of breast cancer tissue samples in the neoadjuvant setting
Journal: Annales de pathologie
Published: November 30, 2018
Myeloperoxidase promotes tube formation, triggers ERK1/2 and Akt pathways and is expressed endogenously in endothelial cells.
Journal: Archives of biochemistry and biophysics
Published: December 22, 2017
The MicroRNA miR-210 Is Expressed by Cancer Cells but Also by the Tumor Microenvironment in Triple-Negative Breast Cancer.
Journal: The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society
Published: April 14, 2017
Last Updated: 09/26/2026